Skip to main content
Top
Published in: BMC Cancer 1/2018

Open Access 01-12-2018 | Research article

Long-term trends in pancreatic cancer mortality in Spain (1952–2012)

Authors: Daniel Seoane-Mato, Olivier Nuñez, Nerea Fernández-de-Larrea, Beatriz Pérez-Gómez, Marina Pollán, Gonzalo López-Abente, Nuria Aragonés

Published in: BMC Cancer | Issue 1/2018

Login to get access

Abstract

Background

Pancreatic cancer is acquiring increasing prominence as a cause of cancer death in the population. The purpose of this study was to analyze long-term pancreatic cancer mortality trends in Spain and evaluate the independent effects of age, death period and birth cohort on these trends.

Methods

Population and mortality data for the period 1952–2012 were obtained from the Spanish National Statistics Institute. Pancreatic cancer deaths were identified using the International Classification of Diseases ICD-6 to ICD-9 (157 code) and ICD-10 (C25 code). Age-specific and age-adjusted mortality rates were computed by sex, region and five-year period. Changes in pancreatic cancer mortality trends were evaluated using joinpoint regression analyses by sex and region. Age-period-cohort log-linear models were fitted separately for each sex, and segmented regression models were used to detect changes in period- and cohort-effect curvatures.

Results

In men, rates increased by 4.1% per annum from 1975 until the mid-1980s and by 1.1% thereafter. In women, there was an increase of 3.6% per annum until the late 1980s, and 1.4% per annum from 1987 to 2012. With reference to the cohort effects, there was an increase in mortality until the generations born in the 1950s in men and a subsequent decline detected by the change point in 1960. A similar trend was observed in women, but the change point occurred 10 years later than in men.

Conclusions

Pancreatic cancer mortality increased over the study period in both sexes and all regions. An important rise in rates -around 4% annually- was registered until the 1980s, and upward trends were more moderate subsequently. The differences among sexes in trends in younger generations may be linked to different past prevalence of exposure to some risk factors, particularly tobacco, which underwent an earlier decrease in men than in women.
Appendix
Available only for authorised users
Literature
1.
go back to reference Ferlay, J. et al. GLOBOCAN 2012 v1.0, Cancer incidence and mortality worldwide: IARC CancerBase No. 11 [Internet]. (International Agency for Research on Cancer, 2013). Ferlay, J. et al. GLOBOCAN 2012 v1.0, Cancer incidence and mortality worldwide: IARC CancerBase No. 11 [Internet]. (International Agency for Research on Cancer, 2013).
2.
go back to reference De Angelis R, et al. Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE--5-a population-based study. Lancet Oncol. 2014;15:23–34.CrossRefPubMed De Angelis R, et al. Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE--5-a population-based study. Lancet Oncol. 2014;15:23–34.CrossRefPubMed
4.
go back to reference López-Abente, G., Núñez, O., Pérez-Gómez, B., Aragonés, N. & Pollán, M. La situación del cáncer en España: Informe 2015. (Centro Nacional de Epidemiología, 2015). López-Abente, G., Núñez, O., Pérez-Gómez, B., Aragonés, N. & Pollán, M. La situación del cáncer en España: Informe 2015. (Centro Nacional de Epidemiología, 2015).
6.
go back to reference Maisonneuve P, Lowenfels AB. Risk factors for pancreatic cancer: a summary review of meta-analytical studies. Int J Epidemiol. 2015;44:186–98.CrossRefPubMed Maisonneuve P, Lowenfels AB. Risk factors for pancreatic cancer: a summary review of meta-analytical studies. Int J Epidemiol. 2015;44:186–98.CrossRefPubMed
7.
go back to reference American Institute for Cancer Research. World Cancer Research Fund. Food, physical activity and the prevention of cancer: a global perspective. (AICR, 2007). American Institute for Cancer Research. World Cancer Research Fund. Food, physical activity and the prevention of cancer: a global perspective. (AICR, 2007).
8.
go back to reference Ekbom A, Trichopoulos D. Pancreatic Cancer. In: Hans-Olov Adami, David Hunter, and Dimitrios Trichopoulos. In: Textbook of Cancer Epidemiology. Second ed. Oxford (United Kingdom): Oxford University Press; 2008. Ekbom A, Trichopoulos D. Pancreatic Cancer. In: Hans-Olov Adami, David Hunter, and Dimitrios Trichopoulos. In: Textbook of Cancer Epidemiology. Second ed. Oxford (United Kingdom): Oxford University Press; 2008.
9.
go back to reference Fritschi L, et al. Occupational exposure to N-nitrosamines and pesticides and risk of pancreatic cancer. Occup Environ Med. 2015;72:678–83.CrossRefPubMed Fritschi L, et al. Occupational exposure to N-nitrosamines and pesticides and risk of pancreatic cancer. Occup Environ Med. 2015;72:678–83.CrossRefPubMed
10.
go back to reference Pace, M. et al. Revision of the European standard population. Report of the Eurostat’s task force. (Publications Office of the European Union, 2013). Pace, M. et al. Revision of the European standard population. Report of the Eurostat’s task force. (Publications Office of the European Union, 2013).
11.
go back to reference Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19:335–51.CrossRefPubMed Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19:335–51.CrossRefPubMed
12.
go back to reference Osmond C, Gardner MJ. Age, period and cohort models applied to cancer mortality rates. Stat Med. 1982;1:245–59.CrossRefPubMed Osmond C, Gardner MJ. Age, period and cohort models applied to cancer mortality rates. Stat Med. 1982;1:245–59.CrossRefPubMed
13.
go back to reference Holford TR. Understanding the effects of age, period, and cohort on incidence and mortality rates. Annu Rev Public Health. 1991;12:425–57.CrossRefPubMed Holford TR. Understanding the effects of age, period, and cohort on incidence and mortality rates. Annu Rev Public Health. 1991;12:425–57.CrossRefPubMed
14.
go back to reference Breslow NE. Extra-Poisson variation in log-linear models. Appl Stat. 1984;33:38–44.CrossRef Breslow NE. Extra-Poisson variation in log-linear models. Appl Stat. 1984;33:38–44.CrossRef
15.
16.
go back to reference Muggeo VM. Segmented: segmented relationships in regression models. R package version. 2004;0:1–4. Muggeo VM. Segmented: segmented relationships in regression models. R package version. 2004;0:1–4.
17.
go back to reference Søreide K, Aagnes B, Møller B, Westgaard A, Bray F. Epidemiology of pancreatic cancer in Norway: trends in incidence, basis of diagnosis and survival 1965-2007. Scand J Gastroenterol. 2010;45:82–92.CrossRefPubMed Søreide K, Aagnes B, Møller B, Westgaard A, Bray F. Epidemiology of pancreatic cancer in Norway: trends in incidence, basis of diagnosis and survival 1965-2007. Scand J Gastroenterol. 2010;45:82–92.CrossRefPubMed
18.
go back to reference Lefebvre A-C, et al. Pancreatic cancer: incidence, treatment and survival trends--1175 cases in calvados (France) from 1978 to 2002. Gastroentérologie Clin Biol. 2009;33:1045–51.CrossRef Lefebvre A-C, et al. Pancreatic cancer: incidence, treatment and survival trends--1175 cases in calvados (France) from 1978 to 2002. Gastroentérologie Clin Biol. 2009;33:1045–51.CrossRef
19.
go back to reference Riall TS, et al. Pancreatic cancer in the general population: improvements in survival over the last decade. J Gastrointest Surg. 2006;10:1212–1223; discussion 1223–1224.CrossRefPubMed Riall TS, et al. Pancreatic cancer in the general population: improvements in survival over the last decade. J Gastrointest Surg. 2006;10:1212–1223; discussion 1223–1224.CrossRefPubMed
20.
go back to reference Bosetti C, et al. Cancer mortality in Europe, 2005-2009, and an overview of trends since 1980. Ann Oncol. 2013;24:2657–71.CrossRefPubMed Bosetti C, et al. Cancer mortality in Europe, 2005-2009, and an overview of trends since 1980. Ann Oncol. 2013;24:2657–71.CrossRefPubMed
21.
go back to reference Ma J, Siegel R, Jemal A. Pancreatic cancer death rates by race among US men and women, 1970-2009. J Natl Cancer Inst. 2013;105:1694–700.CrossRefPubMed Ma J, Siegel R, Jemal A. Pancreatic cancer death rates by race among US men and women, 1970-2009. J Natl Cancer Inst. 2013;105:1694–700.CrossRefPubMed
25.
go back to reference Seoane-Mato D, et al. Trends in oral cavity, pharyngeal, oesophageal and gastric cancer mortality rates in Spain, 1952-2006: an age-period-cohort analysis. BMC Cancer. 2014;14:254.CrossRefPubMedPubMedCentral Seoane-Mato D, et al. Trends in oral cavity, pharyngeal, oesophageal and gastric cancer mortality rates in Spain, 1952-2006: an age-period-cohort analysis. BMC Cancer. 2014;14:254.CrossRefPubMedPubMedCentral
26.
go back to reference Shen Q-W, Yao Q-Y. Total fat consumption and pancreatic cancer risk: a meta-analysis of epidemiologic studies. Eur J Cancer Prev. 2015;24:278–85.CrossRefPubMed Shen Q-W, Yao Q-Y. Total fat consumption and pancreatic cancer risk: a meta-analysis of epidemiologic studies. Eur J Cancer Prev. 2015;24:278–85.CrossRefPubMed
28.
go back to reference Behrens G, et al. Physical activity and risk of pancreatic cancer: a systematic review and meta-analysis. Eur J Epidemiol. 2015;30:279–98.CrossRefPubMed Behrens G, et al. Physical activity and risk of pancreatic cancer: a systematic review and meta-analysis. Eur J Epidemiol. 2015;30:279–98.CrossRefPubMed
29.
go back to reference Farris MS, Mosli MH, McFadden AA, Friedenreich CM, Brenner DR. The association between leisure time physical activity and pancreatic Cancer risk in adults: a systematic review and meta-analysis. Cancer Epidemiol Biomark Prev. 2015;24:1462–73.CrossRef Farris MS, Mosli MH, McFadden AA, Friedenreich CM, Brenner DR. The association between leisure time physical activity and pancreatic Cancer risk in adults: a systematic review and meta-analysis. Cancer Epidemiol Biomark Prev. 2015;24:1462–73.CrossRef
30.
go back to reference Guan H-B, Wu L, Wu Q-J, Zhu J, Gong T. Parity and pancreatic cancer risk: a dose-response meta-analysis of epidemiologic studies. PLoS One. 2014;9:e92738.CrossRefPubMedPubMedCentral Guan H-B, Wu L, Wu Q-J, Zhu J, Gong T. Parity and pancreatic cancer risk: a dose-response meta-analysis of epidemiologic studies. PLoS One. 2014;9:e92738.CrossRefPubMedPubMedCentral
32.
go back to reference Pérez-Gómez B, et al. Accuracy of cancer death certificates in Spain: a summary of available information. Gac Sanit. 2006;20(Suppl 3):42–51.CrossRefPubMed Pérez-Gómez B, et al. Accuracy of cancer death certificates in Spain: a summary of available information. Gac Sanit. 2006;20(Suppl 3):42–51.CrossRefPubMed
Metadata
Title
Long-term trends in pancreatic cancer mortality in Spain (1952–2012)
Authors
Daniel Seoane-Mato
Olivier Nuñez
Nerea Fernández-de-Larrea
Beatriz Pérez-Gómez
Marina Pollán
Gonzalo López-Abente
Nuria Aragonés
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2018
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-018-4494-3

Other articles of this Issue 1/2018

BMC Cancer 1/2018 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine